FDA Eyes Ariad Leukemia Drug After Blood Clot Reports
Ariad Pharmaceuticals Inc.'s leukemia drug Iclusig has drawn the scrutiny of federal regulators amid growing reports of blood clots among patients taking the medication, the U.S. Food and Drug Administration said...To view the full article, register now.
Already a subscriber? Click here to view full article